PillMethylphenidate Hydrochloride
Methylphenidate Hydrochloride
1 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 26, 2023SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Teva Pharmaceuticals USA, Inc.)
Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Psychiatry.
- Jan 27, 2020RECALLRecall (Class II): Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals…
CGMP deviations: Product bottle may be absent of desiccant. — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide
- Jan 27, 2020RECALLRecall (Class II): Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals…
CGMP deviations: Product bottle may be absent of desiccant. — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide